Archives: Agenda

• Ensuring patients are at the forefront of conversations with CROs and vendors
• Considering vendor selection processes with the patient in mind: what does this look like?
• Working closely with patient advocacy groups alongside CROs and vendors to deliver a patientcentric clinical trial

Interactive roundtable sessions offer a unique opportunity to come together with your peers to share best practice and develop solutions to critical challenges facing the industry as a whole. Hosted by industry experts and each focused on a single issue, roundtables are an exciting, interactive way to build your personal network and learn from the experience and expertise of others. Each roundtable lasts for 30minutes, delegates can select up to 2 roundtables.

RT 1 Adapting to change in an evolving industry
Prashanth Chakravartula, Senior Director, Warehouse & Logistics, Bayer

RT 2 How does clinical trial supplies strategy differ between small studies, IST, R-CRC and large phase II and phase III?
Amy Mou, Vendor Strategy Manager – FSP, Pfizer

RT 3 Future-proofing your supply chain to maximize success, how are you doing it? RT 4
The power of the patient voice and the patient-centric future of clinical trial supply

RT 4 The power of the patient voice and the patient-centric future of clinical trial supply

• Take control of supply chain chaos: Preventing drug shortages through robust end-to-end visibility and streamlined workflows
• Fulfilling moral obligations to do better by patients and win the war on counterfeit products
• Why a secure network must remain mission critical: Prioritizing cybersecurity concerns throughout the supply chain to protect patients and healthcare providers
• Maintaining a resilient supply chain strategy amid macroeconomic volatility

Chair: Fiona Barry, Editor-in-Chief and Director of PharmSource, GlobalData

• Leveraging data to predictively build products in time to render your inventory better and less static
• Rethinking your supply strategy through data-driven decision-making capabilities
• How can we intelligently incorporate and optimize the true potential of the supply chain data?
• Adapting to an age of decentralization with live and predictive analytics